Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
450 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04059237 | Pilot Study of a Decision Aid Intervention for Family-building After Cancer | completed | N/A | 102 | Stanford UniversityOTHER | 1 | Apr 9, 2024 | clinicaltrials |
| NCT05526846 | Introducing a Plant-Based Diet for Patients With Colorectal Diseases | unknown | N/A | 60 | Stanford UniversityOTHER | 1 | Mar 28, 2024 | clinicaltrials |
| NCT03856463 |
| Coaches Activating Reaching and Engaging Patients(CAREPlan) |
| completed |
| N/A |
| 400 |
| Stanford UniversityOTHER |
| 1 |
| Mar 21, 2024 |
| clinicaltrials |
| NCT04389918 | Tolerability/Palatability of TalityTM Synthetic Meal Replacement in Prostate Cancer | completed | N/A | 16 | Stanford UniversityOTHER | 1 | Feb 28, 2024 | clinicaltrials |
| NCT02695628 | [18F]FMISO PET/CT After Transcatheter Arterial Embolization in Imaging Tumors in Patients With Liver Cancer | completed | Phase 2 | 5 | Stanford UniversityOTHER | 1 | Jan 31, 2024 | clinicaltrials |
| NCT00928226 | Study of Fractionated Stereotactic Radiosurgery to Treat Large Brain Metastases | completed | N/A | 56 | Stanford UniversityOTHER | 1 | Jan 30, 2024 | clinicaltrials |
| NCT01437449 | Docetaxel, Cisplatin, and Cetuximab (TPC) in Palliative Treatment of Patients With Squamous Cell Carcinoma of the Head and Neck (SCCHN) | completed | Phase 2 | 27 | Stanford UniversityOTHER | 1 | Jan 30, 2024 | clinicaltrials |
| NCT02367859 | Dabrafenib and Trametinib in Treating Patients With BRAF Mutated Ameloblastoma | completed | Phase 2 | 1 | Stanford UniversityOTHER | 1 | Jan 30, 2024 | clinicaltrials |
| NCT02369835 | Modified Dakin's Solution in Reducing Radiation-Induced Dermatitis in Patients With Head and Neck Cancer Undergoing Radiation Therapy | completed | Phase 3 | 132 | Stanford UniversityOTHER | 1 | Jan 30, 2024 | clinicaltrials |
| NCT01769222 | Ipilimumab and Local Radiation for Selected Solid Tumors | terminated | Phase 1 | 3 | Stanford UniversityOTHER | 1 | Jan 24, 2024 | clinicaltrials |
| NCT03657069 | Blossom Smart Expander Technology in Breast Reconstruction in Participants With Breast Cancer Undergoing Mastectomy | completed | N/A | 11 | Stanford UniversityOTHER | 1 | Jan 22, 2024 | clinicaltrials |
| NCT00533780 | Effect of Healing Touch on the Experience of Women Undergoing Treatment for Breast Cancer | completed | N/A | 51 | Stanford UniversityOTHER | 1 | Jan 19, 2024 | clinicaltrials |
| NCT01383135 | Biodistribution and Safety of the PET Probes [18F]FPRGD2 and [18F]FPPRGD2 | completed | Early Phase 1 | 27 | Stanford UniversityOTHER | 1 | Jan 12, 2024 | clinicaltrials |
| NCT00375830 | Combined 18F-NaF/18F-FDG PET/MRI for Detection of Skeletal Metastases | completed | Phase 2 | 114 | Stanford UniversityOTHER | 1 | Dec 12, 2023 | clinicaltrials |
| NCT03734601 | Total Body Irradiation +/- Total Lymphoid Irradiation & Anti-Thymocyte Globulin in Non-myeloablative Hematopoietic Cell Transplantation | completed | Phase 2 | 22 | Stanford UniversityOTHER | 1 | Dec 12, 2023 | clinicaltrials |
| NCT00657332 | Clinical and Pathologic Studies in Neuroendocrine Tumors | withdrawn | — | 0 | Stanford UniversityOTHER | 0 | Nov 28, 2023 | clinicaltrials |
| NCT03367923 | Health and Recovery Program in Increasing Physical Activity Level in Stage IA-IIIA Endometrial Cancer Survivors | completed | Phase 2 | 47 | Stanford UniversityOTHER | 1 | Nov 28, 2023 | clinicaltrials |
| NCT02693080 | CT Perfusion Imaging in Predicting Treatment Response in Patients With Non-small Cell Lung Cancer or Lung Metastases Treated With Stereotactic Ablative Radiation Therapy | completed | Phase 1 | 19 | Stanford UniversityOTHER | 1 | Nov 22, 2023 | clinicaltrials |
| NCT06123416 | Emotion Regulation and Cancer Caregiving | completed | — | 30 | Stanford UniversityOTHER | 1 | Nov 13, 2023 | clinicaltrials |
| NCT04511026 | Concurrent Use Lymphoseek & Indocyanine Green in Sentinel Lymph Node Detection in Endometrial Cancer | terminated | Phase 2 | 6 | Stanford UniversityOTHER | 1 | Oct 11, 2023 | clinicaltrials |
| NCT03620071 | GoalKeeper: Intelligent Information Sharing for Children With Medical Complexity(GoalKeeper) | completed | N/A | 67 | Stanford UniversityOTHER | 1 | Sep 26, 2023 | clinicaltrials |
| NCT02683824 | Integrin Alpha-v-Beta and [18F]-R01-MG-F2 PET/CT in Measuring Response in Patients With Pancreatic Cancer and Healthy Volunteers | completed | Early Phase 1 | 21 | Stanford UniversityOTHER | 1 | Sep 21, 2023 | clinicaltrials |
| NCT03912818 | Durvalumab and Standard Chemotherapy Before Surgery in Treating Patients With Variant Histology Bladder Cancer | terminated | Phase 2 | 7 | Stanford UniversityOTHER | 1 | Sep 11, 2023 | clinicaltrials |
| NCT04018677 | TOGETHER: Track Outcomes and Guidance, Technology for Health and Effective Resources | completed | N/A | 14 | Stanford UniversityOTHER | 1 | Aug 24, 2023 | clinicaltrials |
| NCT00568438 | Immunohistochemical & Immunoblot Analysis of NIS (Na+/I-Symporter) in Archival & Frozen Tissue Sample | completed | — | 169 | Stanford UniversityOTHER | 1 | Aug 3, 2023 | clinicaltrials |
| NCT03520842 | Regorafenib and Methotrexate in Treating Participants With Recurrent or Metastatic KRAS Mutated Non-Small Cell Lung Cancer | completed | Phase 2 | 22 | Stanford UniversityOTHER | 1 | Aug 1, 2023 | clinicaltrials |
| NCT02424955 | Feasibility 3D Perfusion Ultrasound for Liver Cancer SABR Planning and Response Evaluation | completed | N/A | 11 | Stanford UniversityOTHER | 1 | Jul 11, 2023 | clinicaltrials |
| NCT03699748 | Lay Health Worker Engage, Educate, and Encourage Patients to Share(LEAPS) | completed | N/A | 160 | Stanford UniversityOTHER | 1 | Jul 7, 2023 | clinicaltrials |
| NCT00896493 | Ph II of Non-myeloablative Allogeneic Transplantation Using TLI & ATG In Patients w/ Cutaneous T Cell Lymphoma | completed | Phase 2 | 38 | Stanford UniversityOTHER | 1 | May 11, 2023 | clinicaltrials |
| NCT04077372 | Assessment of a Serious Illness Conversation Guide (SICG) in Advanced Gastro-Intestinal Cancers | terminated | N/A | 12 | Stanford UniversityOTHER | 1 | Jan 27, 2023 | clinicaltrials |
| NCT01926197 | Phase 3 Study of FOLFIRINOX (mFFX) +/- SBRT in Locally Advanced Pancreatic Cancer | completed | Phase 3 | 27 | Stanford UniversityOTHER | 2 | Oct 28, 2022 | clinicaltrials |
| NCT02734979 | Prospective Evaluation of a Surgical Solution for Breast Cancer-Associated Lymphedema(Biobridge) | completed | N/A | 1 | Stanford UniversityOTHER | 1 | Oct 27, 2022 | clinicaltrials |
| NCT04843345 | Sjogren's Lung Study | suspended | — | 500 | Stanford UniversityOTHER | 1 | Oct 27, 2022 | clinicaltrials |
| NCT04551014 | Evaluation of EverLift in the Performance of Polypectomy for Polyps 4-9mm | completed | N/A | 158 | Stanford UniversityOTHER | 1 | Sep 1, 2022 | clinicaltrials |
| NCT03050463 | Functional Magnetic Resonance Imaging in Assessing Affect Reactivity and Regulation in Patients With Stage 0-III Breast Cancer | completed | — | 178 | Stanford UniversityOTHER | 1 | Jul 27, 2022 | clinicaltrials |
| NCT00533663 | Healing Touch During Chemotherapy Infusions for Women With Breast Cancer | completed | N/A | 32 | Stanford UniversityOTHER | 1 | Jun 23, 2022 | clinicaltrials |
| NCT00568282 | Identification of Circulating Tumor Cells in the Peripheral Blood of Lung Cancer Patients | completed | — | 219 | Stanford UniversityOTHER | 1 | Jun 22, 2022 | clinicaltrials |
| NCT00373711 | Comparison of I-124 PET/CT, F-18 FDG PET/CT & I-123 Whole Body Scintigraphy for Recurrent Thyroid CA | withdrawn | — | 0 | Stanford UniversityOTHER | 0 | Jun 21, 2022 | clinicaltrials |
| NCT02365883 | Transrectal Photoacoustic Imaging of the Prostate | terminated | — | 22 | Stanford UniversityOTHER | 1 | Jun 14, 2022 | clinicaltrials |
| NCT01631318 | Pilot 3D Contrast-Enhanced Ultrasound Imaging to Predict Treatment Response in Liver Metastases | completed | N/A | 34 | Stanford UniversityOTHER | 1 | Jun 10, 2022 | clinicaltrials |
| NCT00003716 | Monoclonal Antibody Therapy in Treating Patients With Lymphoproliferative Disorder Associated With Immunosuppression Therapy | completed | Phase 2 | 25 | Stanford UniversityOTHER | 1 | May 31, 2022 | clinicaltrials |
| NCT00478465 | Valganciclovir (Valcyte) for Chronic Fatigue Syndrome Patients Who Have Elevated Antibody Titers Against Human Herpes Virus 6 (HHV-6)and Epstein-Barr Virus (EBV) | completed | Phase 1 / Phase 2 | 30 | Stanford UniversityOTHER | 1 | May 27, 2022 | clinicaltrials |
| NCT04551001 | Evaluation of Cold Forcep and Cold Snare Polypectomy for Polyps Less Than or Equal to 3mm in Size During Colonoscopy | completed | N/A | 181 | Stanford UniversityOTHER | 1 | May 17, 2022 | clinicaltrials |
| NCT04200287 | Study to Improve Survivorship Care Related to Fertility and Family-building After Cancer | completed | N/A | 20 | Stanford UniversityOTHER | 1 | May 13, 2022 | clinicaltrials |
| NCT01129687 | Subtotal Resection of Large Acoustic Neuromas With Possible Stereotactic Radiation Therapy | completed | — | 157 | Stanford UniversityOTHER | 1 | May 10, 2022 | clinicaltrials |
| NCT01067144 | Stanford Accelerated Recovery Trial (START) | terminated | Phase 3 | 422 | Stanford UniversityOTHER | 1 | May 5, 2022 | clinicaltrials |
| NCT03081767 | Standard PET/CT vs. Digital PET/CT | completed | N/A | 199 | Stanford UniversityOTHER | 1 | Apr 12, 2022 | clinicaltrials |
| NCT00482157 | Calcitriol or Placebo in Men for Prostate Cancer Active Surveillance | withdrawn | N/A | 0 | Stanford UniversityOTHER | 0 | Mar 3, 2022 | clinicaltrials |
| NCT05247749 | CONVIVO System to Discriminate Healthy Tissues vs Tumor Tissues During Brain Tumor Resection | withdrawn | N/A | 0 | Stanford UniversityOTHER | 0 | Feb 21, 2022 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials